The industry shaping agenda


Reuters Events: Pharma & Patient USA 2020 · Day 1 · December 1, 2020

HERALDING AN UNPRECEDENTED ERA OF PATIENT-CENTRICITY

9:15am - 9:30am (EST) DAY 1

No turning back: Our new arsenal for patient-centric change

  • Herald a new era of industry collaboration in response to changing patient needs
  • Identify the new frontiers of patient-centric change and drive improved outcomes
  • Forge a stronger, more resilient health eco-system to transform patient experience and elevate the patient voice

Dara Richardson-Heron Chief Patient Officer Pfizer

9:30am - 9:45am (EST) DAY 1

Making lemonade from lemons: Positive impacts on clinical research in the wake of COVID-19

  • With a heightened emphasis on the development and adoption of site-based alternatives, hear how clinical research is quickly leveraging new approaches and technologies to broaden patient access and address unmet needs
  • Learn how clinical research is addressing potential disparities in patient access and diversity, post-pandemic
  • An inadvertent positive: Explore how the increased focus on clinical research during this crisis has affected public perception

Pablo Graiver VP, Patient Engagement, Digital Strategy Lead IQVIA

Andy Lee SVP, Head of Global Clinical Trial Operations Merck

9:45am - 10:00am (EST) DAY 1

Joint Q&A

Dara Richardson-Heron Chief Patient Officer Pfizer

Pablo Graiver VP, Patient Engagement, Digital Strategy Lead IQVIA

PLAN AND INNOVATE IN CRISIS

10:00am - 11:00am (EST) DAY 1

Your scorecard: Patient group feedback to pharma’s COVID-19 response

  • Get direct feedback from patients on what barriers to care have arisen during the pandemic, and how you can best support them in conquering these
  • Learn how pharma’s initial response to COVID-19 has addressed pre-existing and new patient needs
  • Optimize your patient engagement to ensure that unprecedented obstacles to adherence are overcome and key outcomes can be met
  • Discuss what practical next steps can be applied to maintain and enhance your patient services in future crisis periods

Molly MacDonald Chief Executive Officer & Founder The Pink Fund

Lara Bloom CEO The Ehlers Danlos Society

Karen Deitemeyer Patient Advocate US COPD Coalition

Amy Niles EVP Patient Access Network (PAN) Foundation

Caitlyn D'Agati Director of Client Services WEGO Health

11:00am - 11:15am (EST) DAY 1

Laurie Cooke in conversation with Lotus Mallbris

Join Laurie Cooke, President and CEO of Healthcare Businesswomen's Association (HBA) in conversation with Lotus Mallbris, VP and Global Head of Immunology Product Development at Eli Lilly, as they discuss:

  • Key strategies for ensuring that research can be more patient-centric
  • How the inclusion of diverse patient populations in research can be successfully prioritized
  • The importance of improving the representation of women at all levels of leadership in pharma

Lotus Mallbris VP and Global Head of Immunology Product Development Eli Lilly

Laurie Cooke CEO and President HBA

11:15am - 12:00pm (EST) DAY 1

Innovating with AI to deliver for patients and HCPs during crisis

  • How operations teams adapted strategy to shorten response times and deliver for patients during the pandemic
  • Reconcile AI and Compliance agendas with a proof of concept, constant monitoring based on Compliance requirements, and an appetite for evolution
  • Harness AI to predict adverse events (AEs), so you can head them off before they happen or manage them more effectively
  • Understand the difference between structured and unstructured data and learn why your AI strategy should feature both

Parag Birla Director of Strategy & Operations ViiV Healthcare

Charlie Guerini Senior Director, Global Operations & Head of Innovation Alphanumeric

Vincent Atalese Operations Manager, GlaxoSmithKline Response Center GlaxoSmithKline

K. Andrew Crighton, MD CEO CEO Roundtable on Cancer

12:00pm - 12:15pm (EST) DAY 1

Adapt your patient services model to support a crisis

  • Assess market shifts and adapt your business to support unmet patient needs during crisis
  • Identify an effective operational approach for executing process change
  • Gain best practices for engaging and communicating with patients and healthcare providers during crisis
  • How to lead patient-centric teams through change and uncertainty

Daniel McNamara VP USBU Patient Services Takeda

Michael D'Agostino VP Patient Engagement & Excellence, US Patient Services Takeda

Debra Jennings Senior Director of Patient Services, Rare Disease Business Unit US Takeda

12:15pm - 12:30pm (EST) DAY 1

Hedging against crisis: Relieving burden on patients participating in clinical trials

  • Effectively evaluate critical risk areas of high patient burden when planning clinical trials and determine how to act on those risks.
  • Drive patient-centered trial design as well as greater study team awareness around areas of patient recruitment or retention risk.
  • Utilize patient burden data to adapt protocol or adequately mitigate potential risks, and support increased enrollment and retention in clinical studies.

Joel Roberts Associate Director, Site & Patient Access Syneos Health

12:30pm - 12:45pm (EST) DAY 1

Adapt to address COVID-19 and its ripple effect of delayed diagnoses

  • Uncover how COVID-19 has impacted treatment management for patients, affecting long-term outcomes
  • See how pharma can leverage new technologies to broaden patient access and address unmet needs
  • Learn ways to address potential disparities in patient access and care provision post-pandemic
  • Explore the future of trials in light of increased attention on research during crisis

Michael Petroutsas, R.Ph SVP, US Oncology Business Unit GlaxoSmithKline

12:30pm - 12:45pm (EST) DAY 1

Joint Q&A

Michael Petroutsas, R.Ph SVP, US Oncology Business Unit GlaxoSmithKline

Daniel McNamara VP USBU Patient Services Takeda

Joel Roberts Associate Director, Site & Patient Access Syneos Health

SOCIAL & NETWORKING

1:30pm - 2:00pm (EST) DAY 1

Virtual networking 101 (Session 1)

It's not enough just to have networking opportunities - you have to know how to get the most out of them! Take advantage of these top networking tips to optimize your time at Pharma & Patient USA and join this interactive session to make meaningful connections virtually, right now!

Brad Pryde Co-Founder & COO OneThree Biotech

DELIVER CO-CREATED DIGITAL PSPs

2:00pm - 2:15pm (EST) DAY 1

Dynamize your projects with ‘living’ patient-generated data

  • How Fox Insight’s extraordinary ‘living database’ of patient-relevant outcomes (PROs) is transforming Parkinson’s research by revealing patients’ lived experience
  • Learn the secret to motivating tens of thousands of patients to contribute their data and how to become agile in response to changing patient needs
  • Discover novel instruments for translating the richness of the patient experience into quantitative metrics, such as natural language processing

Tara Hastings Senior Associate Director, Research Partnerships and Patient Engagement The Michael J. Fox Foundation for Parkinson's Research

2:15pm - 2:30pm (EST) DAY 1

Strategies and trends for maximizing the impact of HCP and patient engagement during the pandemic and beyond

  • Identify new trends and market forces impacting patient and HCP during COVID-19 
  • Understand how biopharma is utilizing Clinical Nurse Educators to maximize support during the pandemic and beyond  
  • Uncover new patient engagement models to maximize your support programs 
     
     

Abigail Mallon SVP, Strategic Accounts & Chief Compliance Officer VMS BioMarketing

2:30pm - 2:45pm (EST) DAY 1

Create patient-centric products with a full eco-system approach to digital design

  • Hear how Teva have improved patient experience and outcomes by taking a holistic approach to product design
  • Build iterative agile design models that prioritize the patient voice at every step while remaining compliant with regulatory requirements
  • Integrate systems and improve communications with HCPs to remove healthcare barriers and add value
  • Explore key solutions to common challenges, including testing, building business models and designing for multi-user environments

Amir Zur Senior Director, Head of Product, Digital Health Teva

2:45pm - 3:00pm (EST) DAY 1

Joint Q&A

Tara Hastings Senior Associate Director, Research Partnerships and Patient Engagement The Michael J. Fox Foundation for Parkinson's Research

Amir Zur Senior Director, Head of Product, Digital Health Teva

Abigail Mallon SVP, Strategic Accounts & Chief Compliance Officer VMS BioMarketing

3:00pm - 3:15pm (EST) DAY 1

Search listening as the cornerstone of a patient-centric strategy

  • Harvest previously inaccessible patient insights from the preliminary ‘consultation’ patients conduct with Dr Google
  • Understand how to use this under-utilised research technique that offers insights rarely available via social listening, keyword tracking and even surveys
  • Inform a genuinely patient-centric and commercially beneficial approach to strategy and catalyze the patient journey towards diagnosis and treatment

Julia Walsh CEO Brand Medicine International

3:15pm - 4:00pm (EST) DAY 1

Disrupt the digital health landscape

  • Surpass competitors with a holistic digital approach that prioritizes patient experience to support adherence and optimize outcomes
  • Key predictions on how patient needs will develop in the ‘Fourth Industrial Revolution’
  • Set KPIs that integrate key insights and data collection to ensure patient needs are addressed

Saleem Hussaini Head of Patient Services IT Biogen

Saket Malhotra Head of Patient Insights & Healthcare Data Science Takeda

Melinda Decker Chief Commercial Officer Mymee

Lilly Stairs Founder and CEO Patient Authentic

Stephanie Bach Director of User Experience Medullan

SOCIAL & NETWORKING

4:00pm - 5:00pm (EST) DAY 1

Speaker meet and greet

Drop into our informal meet and greet to chat with our fantastic speakers and fellow delegates about the presentations of the day and get to know one another - this is the place to unwind and unpack the learnings of Day 1!

Reuters Events: Pharma & Patient USA 2020 · Day 2 · December 2, 2020

ESTABLISH CONNECTIONS THAT DELIVER VALUE

9:15am - 9:30am (EST) DAY 2

Uninterrupted insight: Convert ad-hoc patient engagements into long-term partnerships

  • Explore how the global internal Patient Centricity Network (FPCN) is increasing transparency and cohesion when building patient group partnerships
  • Establish internal patient stakeholders by collaborating with patients to instate disease-specific Patient Advisory Boards
  • How current COVID-19 education initiatives will support long-term engagement with wider patient cohorts, including centralized resource banks, blogging networks and patient-directed podcasts

Ed Trott Chief Patient Officer Ferring Pharmaceuticals

Barbara Collura President and CEO RESOLVE: The National Infertility Association

9:30am - 9:45am (EST) DAY 2

Your patients want connection: How and why to provide peer mentors

  • Hear the surprising results from patient surveys on the need to hear from others living with the same condition
  • Explore how mentor programs work from concept to compliance to execution
  • Discover how mentors sharing their personal journeys can be the most valuable patient support program you can offer your communities
  • Learn how to determine if a mentor program is right for the patients you serve

Jean McCoy SVP, Partnerships Health Perspectives Group

9:45am - 10:00am (EST) DAY 2

Joint Q&A

Ed Trott Chief Patient Officer Ferring Pharmaceuticals

Barbara Collura President and CEO RESOLVE: The National Infertility Association

Jean McCoy SVP, Partnerships Health Perspectives Group

ACTION PATIENT CENTRICITY THROUGHOUT PROGRAM DESIGN

10:15am - 11:00am (EST) DAY 2

Incentivize patient satisfaction to secure patient loyalty

  • Apply new incentives across your business that prioritize patient satisfaction over brand performance to achieve true patient centricity
  • What barriers exist to shifting internal incentives, and how Patient Engagement colleagues are strategizing to overcome these
  • How we can define metrics that measure patient experience, and explore their impacts when met

Heather Mitchell PSP Strategy and Operations Lead Novartis

Heidi Floyd Patient Advocate and Consultant

Lode Dewulf Former Chief Patient Officer Formerly Servier and UCB

Doug Stover Vice President, Global Head of Innovation Alexion Therapeutics

11:00am - 11:15am (EST) DAY 2

The secret behind a patient ready brand

  • Discover the key components of what makes brands patient ready
  • Explore empirical data on patient perceptions of biopharma
  • Learn what some brands do to become more patient ready

Molly Scarborough Associate VP Snow Companies

David Reissner Senior Director, Research & Insights Snow Companies

11:15am - 11:30am (EST) DAY 2

One size does not fit all: Personalize patient support through behavioral science

  • Learn how to predict enrolled patient behaviors and design digitally enabled programs educated by these insights
  • Foster greater adherence by creating holistic patient support initiatives that incorporate individual clinical and psychosocial aspects of disorder
  • Tailor information campaigns using real-world insight into individual interactions to achieve greater behavior change

Kalahn Taylor-Clark, PhD, MPH Global Head of Patient Solutions Sanofi

Sylvie Coumel Global Director, Patient Solutions & Outcomes Sanofi

11:30am - 11:45am (EST) DAY 2

Joint Q&A

Molly Scarborough Associate VP Snow Companies

David Reissner Senior Director, Research & Insights Snow Companies

Sylvie Coumel Global Director, Patient Solutions & Outcomes Sanofi

Kalahn Taylor-Clark, PhD, MPH Global Head of Patient Solutions Sanofi

ESTABLISH CONNECTIONS THAT DELIVER VALUE

12:00pm - 1:00pm (EST) DAY 2

Interactive roundtable: Engage diverse patient groups to maximize positive health outcomes

  • Explore key barriers to effective relationship-building with Black, Latinx and ethnic minority patient groups, and how to overcome these
  • Discuss what language and outreach is most effective for improving health literacy among diverse patient groups
  • Establish collaborative partnerships with minority-led patient organizations and leading Black patient advocates to gain key insights and build trust
  • Review what available resources can support you in empowering and communicating with diverse patient groups

Maimah Karmo Founder and CEO Tigerlily Foundation

12:00pm - 1:00am (EST) DAY 2

Interactive roundtable: Close the loop: Engage key patient Facebook group leaders to supercharge real-world patient insights

  • Collect real-world insights of patients’ experiences to inform patient support program (PSP) design and enable improved adherence
  • Identify patient group leaders to work with, and collaborate on distributing accurate health information and access materials
  • Create formalized feedback opportunities that empower patients and enhance your communications
  • Explore the positive impact of Facebook group membership on patients’ health outcomes

Judith Mayer Patient Advocate and Facebook Fellow Breast Cancer Straight Talk

Shoshana Lipson Patient Advocate Hope in Pain

12:00pm - 1:00pm (EST) DAY 2

Interactive roundtable: Co-creation is the key: Developing health literacy materials that resonate

  • Set patient-centric objectives for creating health literacy materials and promoting their use among patients
  • Identify your audience and decide what messaging will engage them best
  • Collaborate with patient advocates and organizations to co-create effective materials that resonate with patients and caregivers
  • How to ensure educational materials are accessible to different sub-groups within your patient cohort

Leon Rozen Former Senior Medical Director, Oncology Global Medical Affairs Formerly AbbVie

SOCIAL & NETWORKING

1:30pm - 2:00pm (EST) DAY 2

Virtual networking 101 (Session 2)

It's not enough just to have networking opportunities - you have to know how to get the most out of them! Take advantage of these top networking tips to optimize your time at Pharma & Patient USA and join this interactive session to make meaningful connections virtually, right now!

Grace Cordovano CEO & Patient Advocate Enlightening Results

CREATE SCALEABLE PATIENT-CENTRIC R&D

2:00pm - 2:15pm (EST) DAY 2

Utilize data-driven insights to integrate the patient perspective across the drug development continuum

  • Adopt a patient-focused medicines development approach to enable evidence-based decision-making and prioritization through all stages of development
  • How Astellas is convening a multidisciplinary faculty of global experts to uncover some of the most common patient and caregiver issues
  • Collaborate with patients, caregivers and HCPs to compare patients’ social and emotional factors against the big data view of care pathways
  • Leverage validated scales, surveys and other assessments to identify solutions to unmet needs and advance outcomes in the real-world environment

Anthony Yanni SVP and Global Head Patient Centricity Astellas Pharma

2:15pm - 2:30pm (EST) DAY 2

Building a culture of trust: The Department of Veterans Affairs

  • How Medallia have built trust among veteran patients with signal capture and analysis at scale and with speed
  • Gain key tips for including your audience at every step
  • Ways you can create a working culture of experience optimization

Richard Schwartz Life Sciences Industry Practice Lead Medallia

Lee Becker Solutions Principal Medallia

2:30pm - 2:45pm (EST) DAY 2

Pioneer a scalable structure for research that integrates patient engagement

  • How to implement a centralized and coordinated structure for conducting patient research
  • Overcome the resource and budgetary pitfalls of running multiple small-scale patient engagement activities
  • Gain insights from lessons learned to effectively execute patient engagement activities across teams

Alyson Urniasz-Lippel Director, Medical Capabilities, US Oncology Medical Novartis

Pauline Frank Patient Engagement & Insights Director, Oncology Global Medical Affairs Novartis

Therese Johnsen Associate Director, Patient Engagement Management Novartis

2:45pm - 3:00pm (EST) DAY 2

Joint Q&A

Anthony Yanni SVP and Global Head Patient Centricity Astellas Pharma

Alyson Urniasz-Lippel Director, Medical Capabilities, US Oncology Medical Novartis

Richard Schwartz Life Sciences Industry Practice Lead Medallia

3:00pm - 3:15pm (EST) DAY 2

Delivering remarkable patient experiences for clinical trial participants

  • Understand the complexities of the patient journey
  • Review digital technology solutions to enable better outcomes
  • Explore the future of decentralized clinical research

Christopher Kennedy Chief Operating Officer mdgroup

3:15pm - 4:00pm (EST) DAY 2

Minimize patient burden with pre-competitive collaboration

  • Embrace pharma partnerships and collaborate to prevent research demands from causing fatigue among smaller patient populations
  • Avoid replicating basic work carried out by competitors and execute patient engagement activities that break new ground and deliver truly innovative insights
  • Build dynamic relationships with key patient groups and empower them as central conveners of joint strategy for the benefit of multiple clinical teams and patients at once

Wendy Erler VP Head Patient Experience, Insights and Advocacy Alexion Therapeutics

Ryan Fischer Chief Advocacy Officer Parent Project Muscular Dystrophy

Jodi Wolff, PhD Head, Patient Advocacy US Santhera Pharmaceuticals

Jeff Terkowitz VP of Products Inspire

SOCIAL & NETWORKING

4:00pm - 5:00pm (EST) DAY 2

Speaker meet and greet

Drop into our informal meet and greet to chat with our fantastic speakers and fellow delegates about the presentations of the day and get to know one another - this is the place to unwind and unpack the learnings of Day 2!

Reuters Events: Pharma & Patient USA 2020 · Day 3 · December 3, 2020

OPTIMIZE YOUR PATIENT-CENTRIC PRACTICE

9:00am - 9:15am (EST) DAY 3

Amplify the patient voice with Patient Sessions

  • Discover how the FDA conducts patient-led listening sessions to inform regulatory decision-making and early stage research
  • Use FDA session summaries to supplement your patient engagement activities, and inform your understanding of the patient needs in studied disease areas
  • Build multi-directional relationships with patient organizations – how to gather feedback on activities and implement suggestions to enhance future engagement

Andrea Furia-Helms Director, Patient Affairs Staff FDA

Robyn Bent Director of Patient Focused Drug Development FDA

9:15am - 9:30am (EST) DAY 3

The why to the what: How data science and behavioral science have come together to earn change, loyalty and even better health

  • Identify six intrinsic human needs that, if not met, are likely to interrupt a patient’s path to clinical trial participation, start of treatment, or long term adherence to therapy – and uncover new ways to reduce friction along the way.
  • Leverage new, simple segmentation methods to evolve and amplify communications to encourage patient engagement.
  • Utilize best practices in omnichannel to activate motivating, personal content at speed and scale.

Leigh Householder EVP & Managing Director, Kinetic Syneos Health

9:30am - 9:45am (EST) DAY 3

Joint Q&A

Andrea Furia-Helms Director, Patient Affairs Staff FDA

Robyn Bent Director of Patient Focused Drug Development FDA

Leigh Householder EVP & Managing Director, Kinetic Syneos Health

ELEVATE YOUR PATIENT PARTICIPATION STRATEGY

10:00am - 10:45am (EST) DAY 3

Position patients as partners to achieve patient-centric clinical design

  • Advance patient-preferred clinical development by collaborating with patients, advocacy groups and caregivers
  • Explore how you can keep patients’ goals at the forefront of clinical design process
  • Gain best practices for integrating the patient voice in site selection, Principal Investigator (PI) identification and staff training
  • Partner with advocates to better support and prepare patients to participate in research, by enhancing your communication and education strategies

Rosemarie Sellati Global Head of Patient Advocacy-Transplant Novartis

Steven Taylor CEO and President Sjogren’s Foundation

Susan Schaeffer President and CEO The Patients’ Academy for Research Advocacy

Deirdre BeVard SVP R&D Strategic Operations CSL Behring

Dave Fuehrer CEO Gryt Health

10:45am - 11:00am (EST) DAY 3

Not just a checkbox: Make medicines that deliver for all

  • Eli Lilly and Company’s ongoing efforts to reduce participation barriers to ensure a representative population in clinical trials
  • The importance of including pediatric patients in clinical trials, especially in the immunology space, and the strides Lilly has taken in this area
  • Restructure clinical trials to ensure that only the most imperative testing is carried out to counteract patient fatigue and minimize burden
  • Why less is more: Reduce data collection to help patients meet necessary scientific objectives and expand your participant pool
  • Amend your exclusion criteria to enable patients with multiple health conditions – who are disproportionately from minority backgrounds - to participate

Lotus Mallbris VP and Global Head of Immunology Product Development Eli Lilly

11:00am - 11:15am (EST) DAY 3

Improving diversity in clinical research: Let’s ask the patient!

  • Review compelling insights from research with patients from different racial, ethnic, cultural and linguistically diverse groups on the barriers to trial participation
  • Explore feedback from African American and Latino physicians on their views as to how inclusivity and access can be improved
  • Discuss practical methods for addressing these challenges, including ways to build trust with community leaders, improving patient education and partnering effectively with sites

Rosamund Round VP Patient Innovation Center and Decentralized Trials Parexel

11:15am - 11:30am (EST) DAY 3

Decentralize your research to bridge the ‘medical desert’ and boost participation

  • Decrease the burden of patient research with remote engagement and improve patient experience to gain higher quality data
  • Ensure participation in your research is accessible and desirable to patients from diverse geographic and socio-economic subpopulations, and increase your product efficacy
  • Leverage synthetic control arms to relieve patients’ concerns about treatment assignment and incorporate wider data sets into research
  • Gain buy-in from decision-makers to follow through on virtualization strategy

Michael Norton VP Head US Medical Affairs AbbVie

11:30am - 11:45pm (EST) DAY 3

Joint Q&A

Lotus Mallbris VP and Global Head of Immunology Product Development Eli Lilly

Rosamund Round VP Patient Innovation Center and Decentralized Trials Parexel

Michael Norton VP Head US Medical Affairs AbbVie

12:00pm - 1:00pm (EST) DAY 3

Interactive roundtable: Tomorrow’s patients, today: Embrace young adult patients to improve long-term outcomes

  • Uncover the unique needs of young adults, and how they differentiate from those of children and older adults
  • Diversify your research participation – how to enroll and retain young adults in research
  • How to support greater adherence during college and early careers to improve patient outcomes
  • Increase health literacy and industry awareness among young adults to improve access and develop long-term relationships

Seth Rotberg Founder OurOdyssey

12:00pm - 1:00pm (EST) DAY 3

Interactive roundtable: Elevate your collaboration with patient organizations in R&D

  • Identify different methods of effective collaboration with patient organizations in R&D, including focus groups, surveys and signposting to FDA hearings
  • How to plan the “what”, “why” and “when” of outreach to ensure that it is preferential to patients
  • How you can structure your team to enable more productive relationship building with patient organizations

John Linnell Patient Advocate US COPD Coalition

Kip Adams EVP Corporate Relations COPD Foundation

12:00pm - 1:00pm (EST) DAY 3

Interactive roundtable: Empower patients to enrich your participation strategy

  • Gain a 360 perspective of the patient journey, from diagnosis to research participation
  • Support the empowerment of patients with enhanced education materials and direct patient engagement activities
  • Advance the involvement of patients in product design to better identify and accommodate patient needs, and gain the patient perspective on protocol review
  • How to invest your energies to build lasting and productive relationships with patient demographics

Chris Anselmo Market Intelligence Manager Muscular Dystrophy Association

Ella Balasa Patient Advocate United States Adult Cystic Fibrosis Foundation

PATIENT SHARK TANK (PHARMA & PATIENTS ONLY)

Sign up (Pharma) Sign up (Patient)

1:30pm - 5:00pm (EST) DAY 3

Co-design the future of healthcare with patients

  • Engage in a participatory co-design challenge alongside patients
  • Respond to a human-centric problem statement based on obstacles crowd-sourced from patients and care partners
  • Discover a standard methodology for obtaining patient and care/support partner perspectives, which has been co-designed to allow for both quantitative and qualitative insights
  • Gain deeper understanding of pain points and prototype solutions to address obstacles faced by patients
  • Obtain perspectives and feedback from a diverse group of patients and caregivers on prototypes created

Sarah Krüg Founder and CEO Health Collaboratory and Cancer 101

Reuters Events: Pharma & Patient USA 2020 · Day 4 · December 4, 2020

9:00am - 10:00am (EST) DAY 4

SoftServe

Workshop: Improving patient adherence and engagement in the clinical stage of Pharmaceutical development

This interactive workshop will explore:

  • Review of the literature, app features to increase engagement, industry examples
  • Latest technology trends for clinical trials
  • Real-world examples and practices
  • Break-out discussions focused on current experiences

Speakers include:

  • Adam Gabrault, EVP, Healthcare & Life Science, SoftServe
  • Mariya Boychuk, Business Analyst, Healthcare & Life Science, SoftServe

Register now

10:00am - 11:00am (EST) DAY 4

Snow Companies

Workshop: The patient ready panel

This interactive workshop will explore:

  • Hear from your peers how they anchored their brands within the patient community
  • Discuss how a patient landscape analysis helps optimize investment decisions
  • Exchange ideas of where companies should be headed to remain or become patient ready

Speakers include:

  • Chemelle Evans, EVP, Snow Companies
  • Molly Scarbrough, Associate VP, Snow Companies
  • Kip Cross, Director, Customer Engagement, Kite Pharma
  • Christina Zhao, Associate Director, Marketing, Alnylam

Register now

1:00pm - 2:00pm (EST) DAY 4

Medullan

Workshop: Leverage remote patient-generated data

This interactive workshop will explore:

  • How using innovative technology and patient-centric design processes has revolutionized our understanding of the patient journey
  • Discover new insights that remote patient-generated data has uncovered about the patient journey
  • Explore what new possibilities are emerging for patient-centric workstreams based on this new understanding of the patient experience
  • Integrate patient analytics in your strategy to improve brand performance and superior field execution

The session will be led by:

  • Todd Greenwood, Director of Client Solutions, Medullan
  • Tom Mallick, Senior Manager, Digital Strategy, Medullan
  • Lauren Wilson, Digital Strategist, Digital Strategy, Medullan

Register now